Drug & Medication Database

OTC - PURPOSE SECTION Formulated for symptoms such as skin discoloration, discomfort and swelling.

Brands: Edema

Homeopathic combination product formulated for associated symptoms such as throbbing pain, pressure, congestion, dizziness, nausea and light sensitivity.

Brands: Headache

OTC - PURPOSE SECTION Formulated for associated symptoms such as enlarged veins, swelling, discoloration, pain, stinging and heaviness in the legs.

Brands: Varicose Veins

Dosage form: POWDER. Active ingredients: ELBASVIR (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION ZEPATIER is a fixed-dose combination tablet containing elbasvir and grazoprevir for oral administration. Elbasvir is an HCV NS5A inhibitor, and grazoprevir is an HCV NS3/4A protease inhibitor. Each tablet contains 50 mg elbasvir and 100 mg grazoprevir.

Brands: Zepatier

Dosage form: POWDER. Active ingredients: ELBASVIR (20 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.

Purpose External analgesic External analgesic

Brands: Menthol And Methyl Salicylate

Eletriptan hydrobromide tablets contain eletriptan hydrobromide, which is a selective 5-hydroxytryptamine 1B/1D (5-HT1B/1D) receptor agonist. Eletriptan hydrobromide is chemically designated as (R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole monohydrobromide, and it has the following chemical structure: [Chemical Structure] The molecular formula is C22H26N2O2S . HBr, representing a molecular weight of 463.43.

Brands: Eletriptan Hbr

Prescription triptan medication indicated for the acute treatment of migraine with or without aura in adults.

Brands: Eletriptan Hydrobromide

Dosage form: POWDER. Active ingredients: ELETRIPTAN HYDROBROMIDE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELETRIPTAN HYDROBROMIDE (100 kg/100kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELETRIPTAN HYDROBROMIDE MONOHYDRATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELEXACAFTOR (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: TABLET, COATED. Active ingredients: ELEXACAFTOR (100 mg/1); IVACAFTOR (75 mg/1); TEZACAFTOR (50 mg/1). Category: DRUG FOR FURTHER PROCESSING.

11 DESCRIPTION TRIKAFTA is a co-package of elexacaftor, tezacaftor and ivacaftor fixed-dose combination tablets or granules and ivacaftor tablets or granules. Both tablets and granules are for oral administration.

Brands: Trikafta

11 DESCRIPTION CERDELGA (eliglustat) capsules contain eliglustat tartrate, which is a small molecule inhibitor of glucosylceramide synthase that resembles the ceramide substrate for the enzyme, with the chemical name N-((1 R ,2 R )-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide (2 R ,3 R )-2,3-dihydroxysuccinate.

Brands: Cerdelga

Dosage form: POWDER. Active ingredients: ELIGLUSTAT TARTRATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELIGLUSTAT TARTRATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELIGLUSTAT TARTRATE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION LYNKUET is an NK1 and NK3 receptor antagonist. The chemical name of elinzanetant is 2-[3,5-bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]pyridin-3-yl}-N,2-dimethylpropanamide having a molecular formula of C 33 H 35 F 7 N 4 O 3 and a molecular weight of 668.7.

Brands: Lynkuet

11 DESCRIPTION SKYSONA (elivaldogene autotemcel) is an autologous HSC-based gene therapy prepared from the patient's HSCs, which are collected via apheresis procedure(s). The autologous cells are enriched for CD34+ cells, then transduced ex vivo with Lenti-D LVV, and cultured with growth factors overnight. Lenti-D LVV is a replication-incompetent, self-inactivating LVV carrying ABCD1 cDNA that encodes normal ALDP.

Brands: Skysona

Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: ULMUS AMERICANA POLLEN (.05 g/mL). Category: BLA.

Brands: Ulmus Americana Pollen

Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: ULMUS CRASSIFOLIA POLLEN (.05 g/mL). Category: BLA.

Brands: Ulmus Crassifolia Pollen

Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: ULMUS PUMILA POLLEN (.05 g/mL). Category: BLA.

Brands: Ulmus Pumila Pollen

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: ULMUS AMERICANA POLLEN (40000 [PNU]/mL). Category: BLA.

Brands: Pollens - Trees, Elm, American Ulmus Americana

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: ULMUS PARVIFOLIA POLLEN (.05 g/mL). Category: BLA.

Brands: Pollens - Trees, Elm, Chinese Ulmus Parvifolia

Active ingredient (Each 5X HPUS)........... Purpose Bottle 1 : Elm...............................................Be efficient Bottle 2 : Impatiens......................................Have patience Bottle 3 : Vervain.........................................Relax & calm 'HPUS' indicates ingredients are in the official Homeopathic Pharmacopoeia of the United States

Brands: Bach Get It Done Motivation Kit

Dosage form: POWDER. Active ingredients: ELOBIXIBAT MONOHYDRATE (2 kg/2kg). Category: BULK INGREDIENT.

11 DESCRIPTION Elosulfase alfa is a purified human enzyme produced by recombinant DNA technology in a Chinese hamster ovary cell line. Human N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) is a hydrolytic lysosomal glycosaminoglycan-specific enzyme that hydrolyzes sulfate from either galactose-6-sulfate or N-acetyl-galactosamine-6-sulfate on the non-reducing ends of the glycosaminoglycans keratan sulfate (KS) and chondroitin-6-sulfate (C6S).

Brands: Vimizim

11 DESCRIPTION Elotuzumab is a humanized recombinant monoclonal antibody directed to SLAMF7, a cell surface glycoprotein. Elotuzumab consists of the complementary determining regions (CDR) of the mouse antibody, MuLuc63, grafted onto human IgG1 heavy and kappa light chain frameworks. Elotuzumab is produced in NS0 cells by recombinant DNA technology. Elotuzumab has a theoretical mass of 148.1 kDa for the intact antibody.

Brands: Empliciti